Bio-Techne Corporation Profile Avatar - Palmy Investing

Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Scie…
Biotechnology
US, Minneapolis [HQ]

Ratios

14 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
79.76 77.57 74.96 74.41 70.27 67.94 67.46 66.53 67.21 66.31 65.41 67.97 68.42 67.72
Profit Margin
40.80 38.73 35.71 36.24 31.01 23.82 20.94 13.73 19.49 13.46 31.04 15.08 24.61 25.10
Operating Margin
58.10 56.23 52.84 51.02 44.65 32.51 30.18 21.63 21.18 17.59 10.11 16.06 26.83 26.30
EPS Growth
5.71 2.70 - - - - -1.32 -2.67 -4.11 -25.71 61.54 -23.81 134.38 -39.33 90.11 4.62
Return on Assets (ROA)
21.16 18.18 15.62 14.47 12.86 10.13 9.25 4.96 7.87 5.10 11.31 6.20 11.86 10.81
Return on Equity (ROE)
21.88 19.16 16.66 15.26 13.95 12.72 11.88 8.13 11.62 8.24 16.60 8.94 15.99 14.51
Return on Invested Capital (ROIC)
21.86 18.94 17.07 15.05 13.59 10.67 10.53 6.39 9.50 6.45 3.41 7.07 12.77 10.41
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - - - - - - - 1.50 10.91 11.84 22.48 21.84 26.81 21.38 18.58 14.21 17.24
Debt/Equity
- - - - - - - - 1.63 13.70 15.21 36.80 32.24 43.34 31.39 26.77 19.16 23.14
Debt/EBITDA
-61.24 -44.71 -64.40 -97.34 -191.31 41.84 46.17 212.09 159.36 275.54 182.25 93.33 38.58 67.55
Debt/Capitalization
- - - - - - - - 1.60 12.05 13.20 26.90 24.38 30.24 23.89 21.11 16.08 18.79
Interest Debt per Share USD
- - - - - - - - 0.09 0.79 0.91 2.39 2.39 3.49 2.96 2.80 2.15 2.82
Debt Growth
- - - - - - - - - - 796.40 15.26 161.59 -3.12 49.02 -14.18 -2.99 -22.49 39.57
Liquidity
Current Ratio
1,180.92 1,266.86 969.25 1,276.39 1,778.69 624.33 468.89 255.07 506.25 404.58 488.36 335.30 344.03 483.61
Quick Ratio
1,005.60 982.37 857.98 1,162.92 1,558.21 455.03 349.47 202.83 383.85 297.59 368.83 247.52 250.87 328.99
Cash Ratio
581.09 426.73 326.36 510.49 1,207.11 137.13 118.63 67.68 155.03 98.92 137.46 130.74 98.04 140.51
Operating Cash Flow Ratio
600 600 300 300 500 300 200 100 200 100 100 200 100 100
Turnover
Inventory Turnover
396.47 144.80 205.75 227.84 273.77 292.41 284.34 313.32 246.18 264.16 247.69 255.41 247.38 213.76
Receivables Turnover
830.85 765.88 833.47 773.06 747.30 645.75 534.33 481.90 534.51 519.41 602.85 640.39 568.29 520.31
Payables Turnover
1,040.96 1,248.80 1,251.88 1,274.29 533.20 477.01 369.92 337.48 331.71 337.63 403.82 310.74 307.03 474.59
Asset Turnover
51.86 46.94 43.73 39.91 41.48 42.53 44.18 36.17 40.36 37.89 36.43 41.14 48.18 43.08
Coverage
Interest Coverage
- - - - - - - - - - 9,522.22 8,615.16 1,654.45 1,336.65 578.59 389.03 1,071.88 2,622.60 -2,665.57
Asset Coverage
- - - - - - - - 5,600 600 500 200 300 200 300 300 400 400
Cash Flow Coverage (CFGR)
- - - - - - - - 1,056.40 120.09 107.56 41.00 48.97 35.95 47.34 83.74 99.79 55.91
EBITDA Coverage
- - - - - - - - - - 9,500 8,600 1,600 1,300 600 800 1,700 3,500 -3,600
Dividend Coverage
-200 -200 -200 -200 -200 -200 -200 -100 -200 -100 -400 -200 -500 -500
Time Interest Earned (TIE)
300 300 300 300 200 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
1.79 1.28 1.50 1.69 1.33 1.29 1.14 1.08 0.87 0.61 0.48 0.28 0.37 0.39
Earnings Yield
5.13 3.63 4.10 4.39 3.25 2.95 2.49 1.76 2.26 1.22 2.27 0.81 2.00 2.22
Price/Earnings (P/E)
1,949.36 2,753.73 2,440.00 2,280.30 3,077.60 3,390.93 4,014.31 5,673.76 4,423.57 8,230.09 4,399.61 12,425.75 4,997.18 4,497.79
Price/Book (P/B)
426.46 527.62 406.39 348.01 429.36 431.35 476.98 461.18 513.83 678.35 730.39 1,110.40 799.22 652.45
Price/Sales (P/S)
795.37 1,066.52 871.34 826.45 954.41 807.79 840.44 778.86 862.37 1,107.39 1,365.68 1,873.94 1,229.64 1,128.75
Price/Cash Flow (P/CF)
1,923.36 2,431.32 2,162.49 2,077.28 2,496.70 2,621.44 2,915.13 3,056.87 3,254.71 4,353.51 4,915.83 4,954.23 4,179.54 5,043.58
End of TECH's Analysis
CIK: 842023 CUSIP: 09073M104 ISIN: US09073M1045 LEI: - UEI: -
Secondary Listings
TECH has no secondary listings inside our databases.